Last Updated on December 24, 2015 by Joseph Gut – thasso December 24, 2015 – The American Food and Drug Administration (FDA) just approved Lesinurad  (Zurampic) to treat high levels of uric acid in the blood (hyperuricemia) associated with gout, …

Is there help for patients suffering from gout? Lesinurad (Zurampic) approved for the treatment of high blood uric acid levels Read more »

Last Updated on December 21, 2015 by Joseph Gut – thasso December 16, 2015 – This post is somewhat delayed; however, it may still be of  interest for some readers of thasso post and therefore, the information is provided here uncommented, …

Idarucizumab (Praxbind): Antidote for Dabigatran (Pradaxa) approved by FDA and recommended for approval by EMA Read more »

Last Updated on December 12, 2015 by Joseph Gut – thasso December 12, 2015 – The American Food and Drug Administration today approved Alectinib (Alecensa) to treat people with advanced (metastatic) ALK-positive non-small cell lung cancer (NSCLC) whose disease has worsened …

Alectinib (Alecensa) approved for treatment of patients with advanced (metastatic) ALK-positive non-small cell lung cancer (NSCLC) Read more »

Last Updated on December 5, 2015 by Joseph Gut – thasso December 5, 2015 – A safety review by the American Food and Drug Administration (FDA) has resulted in the addition of specific warnings to the drug labels of a specific …

SGLT2 Inhibitors and ketoacidosis: Warnings about too much acid in the blood and serious urinary tract infections included in new drug labels Read more »

Last Updated on December 2, 2015 by Joseph Gut – thasso December 02, 2015 –  The American Food and Drug Administration (FDA) just granted approval for Elotuzumab (Empliciti) in combination with two other therapies to treat people with multiple myeloma who …

Elotuzumab (Empliciti), a new immune-stimulating therapy to treat multiple myeloma has been approved Read more »